Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
about
Molecular pathology of prostate cancerProteomic analysis of formalin-fixed prostate cancer tissue.Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatmentProteomics in clinical trials and practice: present uses and future promise.Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study.Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysisProstate cancer and inflammation: the evidence.Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancerMacrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceExpression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.Mass spectrometry-based expression profiling of clinical prostate cancer.Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancerMolecular biomarkers for cancer detection in blood and bodily fluids.Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.A new frontier in personalized cancer therapy: mapping molecular changes.Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations.The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis.Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification.Diagnostic biomarkers of prostate cancer.Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments
P2860
Q24672410-12EBD9F4-DAA9-4783-A550-A0C2DB87CDCBQ33221442-1AD24A42-899E-4CFF-B81E-696B45D456EBQ33245203-52329384-C6AA-403F-BAEE-36B14FC8E889Q33245305-97226E42-85F1-4FCB-83FD-DAD91D2510E0Q33369053-71A28F3C-3325-40EE-8386-E0A75DD24D7AQ33388693-2CA0810E-CF8D-4883-A321-0516B42A24B5Q33567004-41854958-55DA-4C3E-953F-43E7F1FB0460Q33603811-AB6C2A4E-E0F3-443C-89DE-C08C28277BACQ33642321-2922F0B1-51DB-4267-BDE8-25808215C9CEQ34099900-144E2186-F86F-4659-811B-DA6EC46EE3C4Q34405669-AB5ED7EF-23C0-4333-8687-D5D6CF2222C4Q34505037-EC220C4E-CF5E-43F0-B71A-3A4FC8264914Q34600781-D6BC2BA3-BF07-4E73-BBC0-AD0259D1CD49Q35325174-D31FE0A6-C93C-4B0A-B312-CF2FBEA9A624Q36032608-F802B241-74E4-49C0-A886-7E17E967B30BQ36076068-2FE427D4-67BE-4C28-9358-9300C8991823Q36627755-4FD49E7E-0923-40CD-99FC-40D62D2A2C6DQ36746688-762A3F55-ACE4-45D7-AA7E-F8D8E8C7C9A2Q37117179-263EDBFC-A054-4482-BDD0-04B4BE8C76DCQ37896086-6D23BAE5-1BF3-4861-A05B-8C491CD2258CQ37898108-B279FCBF-330F-4669-B1B2-6EEF811AA80AQ38010665-317D6C0E-EA24-4DB6-8806-A4312DBB9BC1Q39492314-9142E506-ED33-4C1F-8399-CA0599D838B9Q39939421-A4A2157E-7010-4339-B043-32965F7EDDE9Q40302198-B79F6C36-EEDB-416B-AC90-05D3CAD08D21Q41902787-A85462AA-5568-4147-918C-2A65B9483D4BQ42479099-FE2FFE40-3990-472D-B500-D1D90D754B79Q50996571-3CBF8CE5-0FBA-41D3-8178-40B0392A345BQ58773998-A88540A9-0A51-4697-8A94-BE91C712A942
P2860
Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@ast
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@en
type
label
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@ast
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@en
prefLabel
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@ast
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@en
P2093
P1433
P1476
Protein profiling of microdiss ...... 15 to prostate carcinogenesis.
@en
P2093
Bruce Woolcock
Douglas Webber
Edward C Jones
Hans Adomat
Juergen Vielkind
Margaret Sutcliffe
Marianne Sadar
Martin E Gleave
Peter K Cheung
Terry C Bainbridge
P304
P356
10.1158/0008-5472.CAN-04-1216
P407
P50
P577
2004-09-01T00:00:00Z